Search for a trial

A Phase III case series clinical study of the reversal of the anticoagulant effects of dabigatran by intravenous administration of 5.0g idarucizumab (BI 655075) in patients treated wtih dabigatran etexilate who have uncontrolled bleeding or require emergency surgery or procedures.

to investigate the safety and efficacy of idarucizumab in reversing the anticoagulation effect of dabigatran, in patients who have uncontrolled bleeding or require emergency surgery or invasive procedures.

Effects of hyperbaric oxygen therapy on resuscitating mucosal microcirculation and tissue repair in patients who received radiotherapy for malignant disease in the head and neck region

With this study we aim to elucidate the effects of HBOT on the oral microcirculation in patients with malignant disease in the head and neck region after receiving radiotherapy (RT). We want to test the hypothesis that HBOT improves RT-induced…